Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03571841 · ClinicalTrials.gov registry record · NA
Sexual Health and Rehabilitation After Ovarian Suppression Treatment
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03571841 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 20 participants.
The verdict
NCT03571841, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.
Interventions
- BEHAVIORAL Group Session
- BEHAVIORAL Telephone Booster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03571841
The ClinicalTrials.gov registry entry for NCT03571841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Group Session is the first listed.
NCT03571841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03571841 about?
NCT03571841 is a clinical study titled "Sexual Health and Rehabilitation After Ovarian Suppression Treatment". This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.
What is the current status of trial NCT03571841?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-12-01. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03571841?
The interventions under investigation include: Group Session (BEHAVIORAL), Telephone Booster (BEHAVIORAL).
Who is sponsoring clinical trial NCT03571841?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.